Anti-HTLV-III testing--a practical solution for blood transfusion services?
Milner Lv, Vorster Bj, Conradie Jd, Peter Brain
Abstract
Milner Lv, Vorster Bj, Conradie Jd, Peter Brain
Abstract
Screening blood donations for anti-HTLV-III with a modification to a commercially available test kit has so far been found satisfactory--the reagent cost is less than R1.00 a donation. Should all transfusion services adopt this method, South Africa's total blood donations could be tested at a cost of about R650 000, instead of R2.7 million or more, a year.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Screening blood donations for anti-HTLV-III with a modification to a commercially available test kit has so far been found satisfactory--the reagent cost is less than R1.00 a donation. Should all transfusion services adopt this method, South Africa's total blood donations could be tested at a cost of about R650 000, instead of R2.7 million or more, a year.
Key concepts: Medicine, Blood donations, Blood donor, Donation, Blood transfusion, Test (biology), Screening test, Virology